Principal Financial Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-2,613
| Closed | -$25K | – | 2283 |
|
|
2017
Q2 | $25K | Buy |
2,613
+75
| +3% | +$718 | ﹤0.01% | 2253 |
|
|
2017
Q1 | $62K | Sell |
2,538
-164
| -6% | -$4.01K | ﹤0.01% | 2169 |
|
|
2016
Q4 | $87K | Hold |
2,702
| – | – | ﹤0.01% | 2168 |
|
|
2016
Q3 | $135K | Hold |
2,702
| – | – | ﹤0.01% | 2081 |
|
|
2016
Q2 | $115K | Buy |
2,702
+128
| +5% | +$5.45K | ﹤0.01% | 2075 |
|
|
2016
Q1 | $169K | Buy |
2,574
+142
| +6% | +$9.32K | ﹤0.01% | 2042 |
|
|
2015
Q4 | $151K | Buy |
2,432
+64
| +3% | +$3.97K | ﹤0.01% | 2081 |
|
|
2015
Q3 | $159K | Sell |
2,368
-113
| -5% | -$7.59K | ﹤0.01% | 2058 |
|
|
2015
Q2 | $241K | Buy |
2,481
+120
| +5% | +$11.7K | ﹤0.01% | 2002 |
|
|
2015
Q1 | $220K | Buy |
2,361
+186
| +9% | +$17.3K | ﹤0.01% | 2004 |
|
|
2014
Q4 | $193K | Sell |
2,175
-27
| -1% | -$2.4K | ﹤0.01% | 2046 |
|
|
2014
Q3 | $152K | Sell |
2,202
-84
| -4% | -$5.8K | ﹤0.01% | 2072 |
|
|
2014
Q2 | $131K | Buy |
+2,286
| New | +$131K | ﹤0.01% | 2167 |
|
|
2013
Q4 | – | Sell |
-5,749
| Closed | -$172K | – | 2331 |
|
|
2013
Q3 | $172K | Buy |
+5,749
| New | +$172K | ﹤0.01% | 2144 |
|